Skip to content

Molecular & Drug Design

Molecular design, drug screening, and modeling drug–target interactions.

47 papers in this topic (ICML 2026).

★ Spotlight Molecular & Drug Design

From Feasible to Practical: Pareto-Optimal Synthesis Planning

Friedrich Hastedt, Dongda Zhang, Antonio Del rio chanona

Current computer-aided synthesis planning (CASP) methods often treat retrosynthesis as solved once a single feasible route is identified, focusing primarily on convergence or…

Molecular & Drug Design

Derivative Informed Learning of Exchange-Correlation Functionals

Eike Eberhard, Luca Thiede, Abdulrahman Aldossary, Andreas Burger +4

Machine-learned (ML) XC functionals aim to replace human-designed density functional approximations by learning directly from reference data, but they still do not consistently…

Molecular & Drug Design MD & Structural Biology

Speculative Sampling For Faster Molecular Dynamics

Arthur Kosmala, Stephan Günnemann, Meng Gao, Brandon M. Wood

Molecular dynamics (MD) is a key tool for simulating the dynamical behavior of atomic systems. However, MD is inherently serial, which makes it difficult to increase single-system…

Molecular & Drug Design

VecMol: Vector-Field Representations for 3D Molecule Generation

Yuchen Hua, Xingang Peng, Jianzhu Ma, Muhan Zhang

Generative modeling of three-dimensional (3D) molecules is a fundamental yet challenging problem in drug discovery and materials science. Existing approaches typically represent…

Metadata from BioTender-max/icml2026-ai-bio (CC0-1.0).